Principles of memory CD8 T-cells generation in relation to protective immunity

Advances in Experimental Medicine and Biology

Volumn 684, Issue , 2010, Pages 108-125

  Zanetti, Maurizio ^a   Castiglioni, Paola ^b   Ingulli, Elizabeth ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLSERYLASPARAGINYLGLUTAMYLASPARAGINYLMETHIONYLGLUTAMYLTHREONYLMETHIONINE VACCINE; DNA VACCINE; INFLUENZA VACCINE; PEPTIDE VACCINE; UNCLASSIFIED DRUG; VACCINIA VACCINE; ANTIGEN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; CD8+ T LYMPHOCYTE; CELL LINEAGE; CELLULAR IMMUNITY; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; INFLUENZA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RETROVIRUS INFECTION; REVIEW; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS INFECTION; T LYMPHOCYTE SUBPOPULATION; VACCINATION; VIRUS CELL INTERACTION; ANIMAL; CELL DIFFERENTIATION; IMMUNOLOGY;

ANIMALS; ANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS; VACCINATION;

EID: 77956827710     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6451-9_9     Document Type: Review

References (89)

1. Zanetti M. Immunity and protection, the unfolding of a tale. Immunol Res 2007; 38:305-318 (Pubitemid 47574915)
2. Salk J, Zanetti M. Next Step in the Evolution of Vaccinology. Vol. 2. Progress in Vaccinology 1989:451-466
3. Veiga-Fernandes H, Walter U, Bourgeois C et al. Response of naive and memory CD8+ T-cells to antigen stimulation in vivo. Nat Immunol 2000; 1:47-53
4. Lanzavecchia A, Bernasconi N, Traggiai E et al. Understanding and making use of human memory B-cells. Immunol Rev 2006; 211:303-309 (Pubitemid 43882981)
5. Plntkin S Orenstein W. Vaccines. 4th ed. Philadelphia: W.B. Saunders C"., 2004
6. Edghill-Smith Y, Golding H, Manischewitz J et al. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat Med 2005; 11:740-747 (Pubitemid 41021206)
7. Salk J, Salk D. Control of influenza and poliomyclitis with killed virus vaccines. Science 1977; 195:834-847 (Pubitemid 8048141)
8. Kilbourne E, Arden N. Inactivated influenza vaccines. In: Plotkin S, Orenstein W, eds. Vaccines. Philadelphia: W.B. Saunders Co., 1999:531-552
9. Wrammert J, Smith K, Miller J et al Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 29 2008; 453:667-671 (Pubitemid 351769295)
10. Slifica MK, Antia R, Whitmire JK et al. Humoral immunity due to long-lived plasma cells. Immunity 1998; 8:363-372 (Pubitemid 28188896)
11. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B-cells. Science 2002; 298:2199-2202 (Pubitemid 35471246)
12. Paul JR. Riordan JT, Melnick JL. Antibodies to three different antigenic types of poliomyelitis virus in sera from north Alaskan Eskimos. Am J Hyg 1Q51; 54:275-285
13. Panum PL. Beobachtungen uber das masernacontagium. Virchows Archives 1847; 1:492-503
14. Sawyer W. Persistence of yellow fever immunity. J Prevent Med 1930:413-428
15. Crotty S, Felgner P, Davies H et al. Cutting edge: Long-term B-cell memory in humans after smallpox vaccination. J Immunol 2003; 171:4969-4973 (Pubitemid 37432774)
16. Burnet F. The Clonal Selection Theory of Acquired Immunity. London: Cambridge University Press, 1959
17. Zinkernagel RivI, Hengartner H. Regulation of the immune response by antigen. Science 2001; 293 :25 1-25 3 (Pubitemid 32694732)
18. Unanue ER. Perspective on antigen processing and presentation. Immunol Rev 2002; 185:86-102 (Pubitemid 34994934)
19. Bretscher P, Cohn M. A theory of seif-nonseif discrimination. Science 1970; 169:1042-1049
20. Janeway CA Jr, Medzhitov R. Lipoproteins take their toll on the host. Curr Biol 1999; 9:R879-882
21. Ulevitch RJ. Regulation of receptor-dependent activation of the innate immune response. J Infect Dis 2003; l87(Suppl 2):S351-355 (Pubitemid 36724508)
22. Coutinho A, Poltorack A. Innate immunity: From lymphocyte mitogens to toll-like receptors and back. Curr Opin Immunol 2003; 15:599-602 (Pubitemid 37434064)
23. Ahmed R, Gray D. Immunological memory and protective immunity: Understanding their relation. Science 1996; 272:54-60 (Pubitemid 26110754)
24. Murali-Krishna K, Altman JD, Suresh M et al. Counting antigen-specific CD8 T-cells: A reevaluation of bystander activation during viral infection. Immunity 1998; 8:177-187 (Pubitemid 28123745)
25. Kaech SM, Hemby S, Kersh E et al. Molecular and functional profiling of memory CD8 T-cell differentiation. Cell 2002; 111 :83-851
26. Badovinac VP, Messingham KA, Jabbari A et al. Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination. Nat Med 2005; 11:748-756 (Pubitemid 41021207)
27. Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol 2003; 3:269-279 (Pubitemid 37328680)
28. Kaech SM, Ahmed R. Memory CD8+ T-cell differentiation: Initial antigen encounter triggers a developmental program in naive cells. Nat Immunol 2001; 2:41 5-422
29. Mercado R, Vijh S, Allen SE et al. Early programming of T-cell populations responding to bacterial infection. J Immunol 2000; 165:6833-6839 (Pubitemid 32001151)
30. Badovinac VII, Porter BB, Harty JT. Programmed contraction of CD8(+) T-cells after infection. Nat Immunol 2002; 3:619-626 (Pubitemid 34752470)
31. Zanetti M, Franchini G. T-cell memory and protective immunity by vaccination. Is more better? Trends Immunol 2006; 27:511-517 (Pubitemid 44499159)
32. Parish CR. Immune response to chemically modified flagellin. II. Evidence for a fundamental relationship bctwccn humoral and ccll-mcdiatcd immunity. J Exp Med 1971; 134:21-47
33. Hosken NA, Shibuya K, Heath AW et al The effect of antigen dose on CD4+ T helper cell phenotype development in a T-cell receptor-alpha beta-transgenic model. J Exp Med 1995; 182:1579-1584
34. Bretscher PA, Wei G, Menon JN et al. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 1992; 257:539-542
35. Pope C, Kim SK, Marzo A et al. Organ-specific regulation of the CD8 T-cell response to Listeria monocytogenes infection. J Immunol 2001; 166:3402-3409 (Pubitemid 33117342)
36. Bevan MJ, Fink PJ. The CD8 response on autopilot. Nat Immunol 2001; 2:38 1-382
37. Scheller LF, Azad AF. Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. Proc NatI Acad Sci USA 1995; 92:4066-4068
38. Uzonna JE, Wei G, Yurkowski D et al. Immune elimination of Leishmania major in mice: Implications for immune memory, vaccination and reactivation disease. J Immunol 2001; 167:6967-6974 (Pubitemid 33144191)
39. Dudani R, Chapdelaine Y, Faassen Hv H et al. Multiple mechanisms compensate to enhance tumor-protective CD8(+) T-cell response in the long-term despite poor CD8(+) T-cell priming initially : Cuhliparisuhl bct ccii ui acutc vcrsus a c}'ruiiic iiitraccllular bactcriuiii cxprcssihig a inudcl aiitigcn. J Immunol 2002; 168:5737-5745
40. Kundig TM, Bachmann MF, Ohashi PS et al. On T-cell memory: Arguments for antigen dependence. Immunol Rev 1996; 150:63-90 (Pubitemid 26160857)
41. Tanchot C, Lemonnier FA, Perarnau B et al. Differential requirements for survival and proliferation of CD8 naive or memory T-cells. Science 1997; 276:2057-2062 (Pubitemid 27443614)
42. Janssen EM, Lemmens EE, Wolfe T et al. CD4+ T-cells are required for secondary expansion and memory in CD8+ T-lymphocytes. Nature 2003; 421:852-856 (Pubitemid 36254145)
43. Sun JC, Bevan MJ. Defective CD8 T-cell memory following acute infection without CD4 T-celI help. Science 2003; 300:339-342 (Pubitemid 36433727)
44. Sun JC, Williams MA, Bevan MJ. CD4+ T-cells are required for the maintenance, not programming, of memory CD8+ T-cells after acute infection. Nat Immunol 2004; 5:927-933 (Pubitemid 39276237)
45. Wang JC, Livingstone AM. Cutting edge: CD4+ T-cell help can be essential for primary CD8+ T-cell responses in vivo. J Immunol 2003; 171:6339-6343. (Pubitemid 37532059)
46. Shedlock DJ, Shen H. Requirement for Cfl+ T-cell help in generating functional CD8 T-cell memory. Science 2003; 300:337-339 (Pubitemid 36433726)
47. Langlade-Demoyen P. Garcia-Pons F, Castiglioni P et al. Role of T-cell help and endoplasmic reticulum targeting in protective CTL response against influenza virus. Eur J Immunol 2003; 33:720-728 (Pubitemid 36367675)
48. Janssen EM, Droin NM, Lemmens EE et al. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 2005; 434:88-93 (Pubitemid 40349390)
49. Berner V, Liu H, Zhou Q et al IFN-gamma mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy. Nat Med 2007; 13:354-360 (Pubitemid 46376686)
50. Bartholdy C, Kauffmann SO, Christensen JP et al. Agonistic anti-CD4O antibody profoundly suppresses the immune response to infection with lymphocytie choriomeningitis virus. J Immunol 2007; 178:1662-1670 (Pubitemid 46154638)
51. Hayfliek L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965; 37:6 1 4-6 36
52. Akbar AN, Beverley PC, Salmon M. Will telomere erosion lead to a loss of T-cell memory? Nat Rev Immunol 2004; 4:737-743 (Pubitemid 39223079)
53. Onyang Q, Wagner WM, Zheng W et al Dysfunctional CMV-specific CD8(+) T-eells accumulate in the elderly. Exp Geronrol 2004; 39:607-613 (Pubitemid 38402087)
54. Brenchley JM, Karandikar NJ, Betts MR et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T-cells. Blood 2003; 101:2711-2720 (Pubitemid 36857634)
55. Ibegbu CC, Xu YX, Harris Wet al. Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T-lymphocytes during active, latent and resolved infection and its relation with CD5. J Immunol 2005; 174:6088-6094 (Pubitemid 40663797)
56. Papagno L, Spina CA, Marchant A et al Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol 2004; 2:E20
57. Sallusto F, Lenig D, Forster R et al. Two subsets of memory T-lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-712
58. Masopust D, Vezys V. Marzo AL et al. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291:2413-2417 (Pubitemid 32231804)
59. Wherry EJ, Teichgraber V. Becker TC et al Lineage relationship and protective immunity of memory CD8 T-cell subsets. Nat Immunol 2003; 4:225-234 (Pubitemid 36322131)
60. Barber DL, Wherry EJ, Ahmed R. Cutting Edge: Rapid in vivo killing by memory CD8 T-cells. J Immunol 2003; 171:27-31 (Pubitemid 36745269)
61. Lanzavecchia A, Sallusto F. Dynamics of T-lymphocyte responses: Intermediates, effectors and memory cells. Science 2000; 290:92-97
62. Baron V. Bouneaud C, Cumano A et al The repertoires of circulating human CD8(+) ccntral and effector memory T-cell subsets are largely distinct. Immunity 2003; 18:193-204 (Pubitemid 36262995)
63. Marzo AL, Klonowski KD, Le Bon A et al. Initial T-cell frequency dictates memory CD8+ T-cell lineage commitment. Nat Immunol 2005; 6:793-799 (Pubitemid 43090465)
64. Obar JJ, Khanna KM, Lefrancois L. Endogenous naive CD8+ T-cell precursor frequency regulates primary and memory responses to infection. Immunity 2008; 28:859-869
65. Allan W, Tabi Z, Cleary A et al. Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T-cells. J Immunol 1990; 144:3980-3986 (Pubitemid 20171213)
66. Lukacher AE, Braciale VL, Braciale TJ. In vivo effector function of influenza virus-specific cytotoxic T-lymphocyte clones is highly specific. J Exp Med 1984; 160:814-826 (Pubitemid 14074780)
67. Epstein SL, Lo CY, Misplon JA et al. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J Immunol 1998; 160:322-327 (Pubitemid 28116745)
68. Doherty PC, Christensen JP. Accessing complexity: The dynamics of virus-specific T-cell responses. Annu Rev Immunol 2000; 18:561-592 (Pubitemid 30365391)
69. Zantti M, Castigliuni P. Rizzi M t al. B-lymphucyts as APC based gntic vaccines. Immunul Rv 2004; 199:264-278
70. Bastin J, Rothbard J, Davey J et al. Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T-lymphocytes. J Exp Med 1987; 165:1508-1523 (Pubitemid 17087904)
71. Gerloni M, Rizzi M, Castiglioni P et al. T-cell immunity using transgenic B-lymphocytes. Proc Natl Acad Sci USA 2004; 101:3892-3897 (Pubitemid 38381073)
72. Castiglioni P. Gerloni M, Zanetti M. Genetically programmed B-lymphocytes are highly efficient in inducing anti-virus protective immunity by central memory CD8 T-cells. Vaccine 2004; 23:699-708 (Pubitemid 39473202)
73. Vaccari M, Trindade CJ, Venzon D et al. Vaccine-induced CD8+ central memory T-cells in protection from simian AIDS. J Immunol 2005; 175:3502-3507 (Pubitemid 41292007)
74. Rd Z, Nacsa J, Tryniszewska E et al. Containment of simian immunodeficiency virus infection in vaccinated macaques: Correlation with the magnitude of virus-specific pre and postchallenge CD4+ and CD8+ T-cell responses. J Immunol 2002; 169:4778-4787 (Pubitemid 35217140)
75. Rd Z, Johnson JM, Tryniszewska E et al. A novel chimeric Rev, Tat and Nef (Retanef) antigen as a component of an SlY/HIV. vaccine Vaccine 2002; 20:311-3186
76. Joshi NS, Cui W, Chandele A et al. Inflammation directs memory precursor and short-lived effector CD8(+) T-cell fates via the graded expression of T-bet transcription factor. Immunity 2007; 27:281-295 (Pubitemid 47284924)
77. Lee D, Graham BS, Chiu YL et al. Breakthrough infections during phase 1 and 2 prime-boost RIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gpl2O or gpl6O. J Infect Dis 2004; 190:903-907 (Pubitemid 39120966)
78. Cohen J. HIV AIDS. Hedged bet: An unusual AIDS vaccine trial. Science 2005; 309:1003
79. Ingulli E, Funatake C, Jacovetty EL et al Antigen presentation to CD8 T-cells after influenza A virus infection. J Immunol 2009; 182:29-33
80. Lo D, Qll H, Burkly L et al. A recessive defect in lymphocyte or granulocyte function caused by an integrated transgene. Am J Pathol 1992; 141:1237-1246
81. Wu L, D'Amico A, Winkel KD et al. Re1B is essential for the development of myeloid-related CD8alpha-dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. Immunity 1998; 9:839-847 (Pubitemid 29024463)
82. Burkly L, Hession C, Ogata L et al. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 1995; 373:531-536
83. Castiglioni P. Janssen EM, Prilliman KR et al. Cross-priming is under control of the relB gene. Scand J Immunol 2002; 56:219-223 (Pubitemid 35002025)
84. Castiglioni P, Lu C, Lo D et al. CD4 T-cell priming in dendritic cell-deficient mice. Tnt Immunol 2003; 15:127-136 (Pubitemid 36163775)
85. Zanetti M, Castiglioni P. Schoenberger S et al. The Role of relB in Regulating the Adaptive Immune Response. Ann N Y Acad Sci 2003; 987:249-257 (Pubitemid 36584030)
86. Castiglioni P, Hall de S, Jacovetty EL et al. Protection against Influenza A Virus by Memory CD8 T-Cells Requires Reactivation by Bone Marrow-Derived Dendritic Cells. J Immunol 2008; 180:4956-4964
87. Wing RF, Wing HY. Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells. Nat Biotechnol 2002; 20:149-154
88. Wherry EJ, Blattman JN, Ahmed R. Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination. J Virol 2005; 79:8960-8968 (Pubitemid 40934807)
89. Williams MA, Bevan MJ. Shortening the infectious period does not alter expansion of CD8 T-cells but diminishes their capacity to differentiate into memory cells. J Immunol 2004; 173:6694-6702. (Pubitemid 39541054)